BioSpace News Archive

A new highly selective treatment, a peroxisome proliferator-activated receptor alpha modulator (SPPARM-alpha) agonist, may help to address the gap in managing the residual risk of heart attacks and strokes in high-risk patients, according to over 50 world-leading experts from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i).

Novaremed AG announced that it has secured CHF2.6 million in additional financing from its existing shareholders and several new private investors.

New NanoWizard 4 XP Provides Extreme Imaging Performance and Ease of Use

The world famous medical journal The Lancet has published the results of a two year health impact trial in Bangladesh

“I was working in my shop, and I grew tired of having to go into the house every time I needed to wash my hands,” said an inventor from Missouri City, Texas. “This inspired me to develop a convenient mobile hand-washing station that can be set up and used wherever it is needed.”